Brittany Knick Ragon, MD¹, Danielle Boselli, MS^2*, Rupali Bose, MS, MBA^2*, Stephanie Begley, MS^2*, Melissa Aguiar, MSN^3*, Kris Blackley, MSN^3*, Nilay Shah, MD^1*, Aleksander L. Chojecki, MD¹, Srinivasa Reddy Sanikommu, MD¹, Yifan Pang, MD¹, Jing Ai, MD, PhD¹, Belinda Avalos, MD¹, Edward A. Copelan, MD¹, Thomas G. Knight, MD¹ and Michael R. Grunwald¹

¹Department of Hematologic Oncology and Blood Disorders, Atrium Health Levine Cancer Institute, Charlotte, NC
²Department of Biostatistics and Data Sciences, Atrium Health Levine Cancer Institute, Charlotte, NC
³Department of Supportive Oncology, Atrium Health Levine Cancer Institute, Charlotte, NC

George Dranitsaris, PhD, MS, BPharm^1*, Dakota Powell, MPH^2*, Heather Neuhalfen, BSN, MBA^3*, Aaron Peevyhouse, MS^3*, Kerri Miller, PharmD^4*, Teresa Green, MSPH^2* and Tara Graff, DO, MS⁵

¹Department of Public Health, Syracuse University, Syracuse
²Blueprint Medicines Corporation, Cambridge, MA
³QCCA Network, LLC, Tacoma, WA
⁴BluePrint Medicines, Cambridge
⁵Mission Cancer + Blood, Des Moines, IA

Fabio Efficace, PhD^1*, Laura Cannella^1*, Xavier Thomas, MD, PhD^2*, Meltem Kurt Yuksel, MD^3*, Silvia Maria Trisolini^4*, Capria Saveria^4*, Alberto Brini^1*, Ernesta Audisio, MD^5*, Luca Maurillo, MD^6*, Roberto Massimo Lemoli, MD^7*, Annalisa Imovilli^8*, Irina Panovska Stavridis, PhD^9*, Martina Quattrone^10*, Maria Ciccone^11*, Nunzio Filardi^12*, Nicola Fracchiolla, MD^13*, Daniele Vallisa, MD^14*, Monica Crugnola, MD^15*, Lorella Maria Antonia Melillo, MD^16*, Matevz Skerget, MD, PhD^17*, Marco Vignetti, MD^1* and Frederic Baron¹⁸

¹Italian Group for Adult Hematologic Diseases (GIMEMA), Data Center and Health Outcomes Research Unit, Rome, Italy
²Hospices Civils de Lyon, Department of Clinical Hematology, Centre Hospitalier Lyon-Sud, Pierre Bénite, Lyon, France
³Department of Hematology, Ankara University Faculty of Medicine, Ankara, Turkey
⁴Haematology, Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy
⁵SC Ematologia 2, AOU Città della Salute e della Scienza, Turin, Italy
⁶Hematology, Fondazione Policlinico Tor Vergata, Rome, Italy
⁷Clinica Ematologica, Dipartimento di Oncologia e Ematologia, IRCCS Ospedale Policlinico San Martino, Genoa, Italy
⁸Hematology, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy
⁹University Clinic for Hematology, Skopije, Macedonia, The former Yugoslav Republic of
¹⁰Hematology, Università Cattolica del Sacro Cuore, Rome, Italy
¹¹Hematology Section, Department of Medical Sciences, AOU Arcispedale S.Anna, Ferrara, Italy
¹²UOC di Ematologia, Azienda Ospedaliera Regionale "San Carlo", Potenza, Italy
¹³UOC Oncoematologia, Fondazione IRCCS "Ca'Granda" Ospedale Maggiore Policlinico, Milan, Italy
¹⁴Hematology Unit, Ospedale Guglielmo da Saliceto, Piacenza, Italy
¹⁵Hematology Unit and BMT, University Hospital of Parma, Parma, Italy
¹⁶UO Ematologia, Ospedale "Casa Sollievo della Sofferenza" IRCCS, San Giovanni Rotondo, Italy
¹⁷Department of Haematology, University Medical Centre Ljubljana, Ljubljana, Slovenia; Medical Faculty, University of Ljubljana, Ljubljana, Slovenia
¹⁸CHU Sart Tilman, Division of Hematology, University of Liège, Liège, Belgium

Kellen Tjioe, PhD^1*, Marisol Miranda-Galvis, DDS, MSc, PhD^1*, Thalyta Medeiros, MD^1*, Kenza Mamouni, PhD, MBA^1*, Brenda Santellano, MD^1*, Claudia Guillen, MD^1* and Jorge Cortes, MD²

¹Georgia Cancer Center at Augusta University, Augusta, GA
²Georgia Cancer Center, Augusta University, Augusta, GA

Michael R. Grunwald¹, Aaron T. Gerds, MD, MS², Apurv Agrawal^3*, Evan M. Braunstein, MD, PhD^4*, JE Hamer-Maansson, MSPH^4*, Tricia Kalafut^4* and John Mascarenhas, MD^5*

¹Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, NC
²Cleveland Clinic Taussig Cancer Institute, Cleveland, OH
³New Jersey Hematology Oncology Associates, Brick Township, NJ
⁴Incyte Corporation, Wilmington, DE
⁵Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY

Francesco Sparano^1*, Adriano Venditti, MD², Maria Teresa Voso, MD², Johannes M. Giesinger^3*, Alberto Brini^1*, Paola Fazi, MD^1*, Marco Vignetti, MD^1* and Fabio Efficace, PhD^1*

¹Data Center and Health Outcomes Research Unit, Italian Group for Adult Haematologic Diseases (GIMEMA), Rome, Italy
²Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy
³University Hospital of Psychiatry II, Medical University of Innsbruck, Innsbruck, Austria

Akshee Batra, MBBS^1*, Andrew Sparks, MS^2*, Rohit Singh, MD^3*, Atulya Aman Khosla, MBBS⁴, Neil Zakai³ and Diego Adrianzen Herrera, MD³

¹Department of Internal Medicine, University of Vermont Medical Center, Winooski, VT
²Biomedical Statistics Research Core at the University of Vermont, Burlington, VT
³Division of Hematology and Oncology, Larner College of Medicine at the University of Vermont, Burlington, VT
⁴Department of Internal Medicine, Beaumont Hospital (Royal Oak), Troy, MI

Andrew Palmer, BS^1*, Garth Rauscher^2*, Ivy Abraham, MD^3*, Madelyn Burkart, MD⁴, Ami Dave, MD^5*, Nepheli Raptis, MA, BA⁶, Ahmed Aleem, MD^7*, Vedavyas Gannamani, MD⁸, Amani Erra, MD^8*, Sarah Monick, MD^9*, Carlos Galvez, MD¹⁰, Melissa L. Larson, MD¹¹, Maryam Zia, MD¹², Stephanie B. Tsai, MD, MS¹³, Jessica K. Altman, MD¹⁴, Wendy Stock, MD¹⁵, Irum Khan, MD⁴ and Anand Ashwin Patel, MD¹⁶

¹University of Chicago Pritzker School of Medicine, Chicago, IL
²University of Illinois At Chicago School of Public Health, Chicago, IL
³UChicago Medicine, Chicago, IL
⁴Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL
⁵Division of Hematology, Oncology and Stem Cell Transplant, Rush University, Chicago
⁶Loyola University Stritch School of Medicine, Maywood, IL
⁷Division of Hematology and Oncology, Loyola University Medical Center, Maywood, IL
⁸Division of Hematology and Oncology, John H. Stroger Jr. Hospital of Cook County, Chicago, IL
⁹Department of Medicine, University of Chicago, Chicago, IL
¹⁰Division of Hematology/Oncology, University of Illinois at Chicago, Chicago, IL
¹¹Division of Hematology, Oncology and Stem Cell Transplant, Rush University Medical Center, Chicago, IL
¹²Division of Hematology and Oncology, John H. Stroger Hospital of Cook County, Chicago, IL
¹³Loyola University Medical Center, Maywood, IL
¹⁴Department of Medicine, Division of Hematology/Oncology and the Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Northwestern University Feinberg School of Medicine, Chicago, IL
¹⁵The University of Chicago Medical Center, Chicago, IL
¹⁶Section of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, IL

Richa Thakur, MD¹, Stephanie Boisclair, MD², Phyu Thin Naing, MBBS³, Edward Zhou, MD³, Bradley Goldberg, MD⁴, Erin Jou, MD⁴, Jonathan E Kolitz, MD⁵ and David W Chitty, DO, MSc⁶

¹Zuckerberg Cancer Center, New Hyde Park
²Northwell Health, Zuckerberg Cancer Center, Lake Success, NY
³Zuckerberg Cancer Center, New Hyde Park, NY
⁴Zuckerberg Cancer Center, Lake Success, NY
⁵Northwell Health, Lake Success, NY
⁶Zuckerberg Cancer Center, Northwell Health, New Hyde Park, NY

Leslie A. Andritsos¹, Kirollos S. Hanna^2*, Enrico Zanardo, PhD^3*, Ali McBride, PharmD⁴, Victoria Barghout^5*, Rui Song^6*, Lynn Huynh, DrPH, MBA, MPH^7*, Derek Tang^4*, Mihran Yenikomshian^6* and Kashyap Patel^8*

¹University of New Mexico, Albuquerque, NM
²Minnesota Oncology, Minneapolis, MN
³Analysis Group, Denver, CO
⁴Bristol Myers Squibb, Princeton, NJ
⁵VEB Healthcare, Morristown, NJ
⁶Analysis Group, Boston, MA
⁷Analysis Group, Inc., Boston, MA
⁸Carolina Blood and Cancer Care Associates, Rock Hill, SC

Daniel J Olivieri, MD¹, Megan Othus, PhD², Corentin Orvain^3,4,5,6*, Eduardo Rodríguez-Arbolí, MD^3,7*, Filippo Milano, MD^3,8, Brenda M. Sandmaier, MD^3,9, Irum Khan, MD¹⁰, Chris Davis^11*, Ryan S. Basom^11*, Frederick R. Appelbaum, MD^9,12 and Roland B. Walter, MD, PhD, MS^3,13,14

¹Department of Medicine, Internal Medicine Residency Program, University of Washington, Seattle, WA
²Public Health Science Division, Fred Hutchinson Cancer Center, Seattle, WA
³Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA
⁴Fédération Hospitalo-Universitaire Grand-Ouest Acute Leukemia, Angers, France
⁵Hematology Department, Angers University Hospital, Angers, France
⁶Maladies du Sang, CHU d’Angers, Angers, France
⁷Department of Hematology, Hospital Universitario Virgen del Rocío, Instituto de Biomedicina de Sevilla, University of Seville, Seville, Spain
⁸Division of Hematology and Oncology, University of Washington, Seattle, WA
⁹Department of Medicine, Division of Medical Oncology, University of Washington, Seattle, WA
¹⁰Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL
¹¹Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA
¹²Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA
¹³Division of Hematology, Department of Medicine, University of Washington, Seattle, WA
¹⁴Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA

Zhuo-Yu An^1*, Haixia Fu, MD^1*, Yun He^1*, Xiaolu Zhu, MD^2*, Qiu-Sha Huang^3*, Jin Wu^4*, Kaiyan Liu⁵ and Xiaohui Zhang, MD^6*

¹Peking University People's Hospital, Peking University Institute of Hematology, Beijing, China
²Peking University Institute of Hematology, Peking University People’s Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China
³Peking University People's Hospital, Peking University Institute of Hematology, Beijing, CHN
⁴Peking University People’s Hospital, Beijing, MD, China
⁵Peking University People’s Hospital, Beijing, China, Beijing, CHN
⁶Peking University People's Hospital, Beijing, China

Jeff Aguilar, MD, MBA¹, Dakshin Padmanabhan, MBBS², Gregory Dyson, PhD^3* and Suresh Kumar Balasubramanian, MD^3,4

¹Department of Oncology, Karmanos Cancer Institute/Wayne State University, Windsor, ON, Canada
²St Joseph Mercy Oakland (Trinity Health) Hospital, Rochester Hills, MI
³Karmanos Cancer Institute/Department of Oncology, Wayne State University, Detroit, MI
⁴Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH

Stephen T. Oh, MD, PhD¹, Naveen Pemmaraju, MD², Niyati Nathwani^3*, Evan M. Braunstein, MD, PhD^4*, JE Hamer-Maansson, MSPH^4*, Tricia Kalafut^4* and Ellen K. Ritchie, MD⁵

¹Department of Medicine, Washington University School of Medicine, Saint Louis, MO
²Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
³Carolina Blood and Cancer Care Associates, Lancaster, SC
⁴Incyte Corporation, Wilmington, DE
⁵Weill Cornell Medical College, Cornell University, New York, NY

Nathalie Arielle Loeb, MD^1*, Olivia Katsnelson^2*, Anshika Jain, MD^1*, Parsa Tahvildar, MD^1*, Daniel Teitelbaum, MD^3* and Alejandro Garcia-Horton, MD⁴

¹Department of Internal Medicine, McMaster University, Hamilton, ON, Canada
²York University, Toronto, Canada
³Department of Internal Medicine, University of Toronto, Toronto, Canada
⁴Department of Oncology, McMaster University, Hamilton, ON, Canada

Tapan M. Kadia, MD¹, Alex Bataller, MD, PhD^1*, Esprit Ma, MPH^2*, Achal Patel, PhD^2*, Rongrong Wang, MPH^2*, Archibong Yellow-Duke, PharmD^2*, Melissa Montez, PharmD^2*, Cat N. Bui, PharmD, PhD^3* and Farhad Ravandi, MD, MBBS⁴

¹MD Anderson, Houston, TX
²Genentech, Inc., South San Francisco, CA
³AbbVie, Inc., Chicago, IL
⁴Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX

Hélène Kemp^1*, Laurène Fenwarth, MD, MSc^2*, Delphine Lebon^3*, Nicolas Duployez, PharmD, PhD^4*, Etienne Paubelle^3*, Magalie Joris, MD^3*, Amandine Charbonnier, MD^5*, Lydia Montes, MD^5*, Claude Preudhomme, PharmD, PhD^4*, Christophe Tribouilloy^6*, Jean Pierre Marolleau, MD, PhD⁵ and Pierre Morel, MD^5*

¹Service d’Hématologie Clinique, Centre Hospitalier Universitaire Amiens-Picardie, AMIENS, AL, France
²Hematology Laboratory, CHU Lille, Lille, France
³Service d’Hématologie Clinique, Centre Hospitalier Universitaire Amiens-Picardie, Amiens, FRA
⁴Laboratory of Hematology, Centre Hospitalier Universitaire (CHU) Lille, Lille, France
⁵Service d’Hématologie Clinique, Centre Hospitalier Universitaire Amiens-Picardie, Amiens, France
⁶Service de Cardiologie, CHU AMIENS PICARDIE, AMIENS, France

Joshua F. Zeidner, MD¹, Priyanka Mehta, MD, FRCPath, MRCP^2*, Benyam Muluneh^3*, Sarah Bertoli^4*, Pierre-Yves Dumas, MD, PhD^5*, Arnaud Pigneux, MD, PhD^6*, Cédric Fernandez^7*, Hélène Derrien^7* and Christian Recher, MD, PhD^8*

¹University of North Carolina, Lineberger Comprehensive Cancer Center, Chapel Hill, NC
²University Hospitals Bristol NHS Foundation Trust, Bristol, GBR
³University of North Carolina, Chapel Hill
⁴Service d'Hématologie, Centre Hospitalo-universitaire de Toulouse, Centre de Recherches en Cancérologie de Toulouse, Institut Universitaire du Cancer de Toulouse-Oncopole, Université de Toulouse, UPS, INSERM, CNRS, Toulouse, France, Toulouse, France
⁵Hôpital Haut-Lévèque, Hematology Department, CHU Bordeaux, Pessac, France
⁶Hématologie Clinique et Thérapie cellulaire, CHU Bordeaux, Bordeaux, France
⁷Servier, Suresnes, France
⁸Hematology Department, CHU de Toulouse - Institut Universitaire du Cancer de Toulouse Oncopole, Toulouse, France